Repositioning gemigliptin for the alleviation of thioacetamide-induced liver fibrosis in rats: Targeting TLR4/MAPK, SIRT1/AMPK/Nrf2, PI3K/AKT/mTOR axis and apoptosis

Riyadh S. Almalki(Umm al-Qura University), Marawan A. Elbaset(National Research Centre), Samar F. Miski(Taibah University), Alyaa F. Hessin(National Research Centre), Malaz Gazzaz(Umm al-Qura University), Reda M. S. Korany(Cairo University), Hany M. Fayed(National Research Centre), Sherif M. Afifi(University of Sadat City), Bassim M. S. A. Mohamed(National Research Centre), Tuba Esatbeyoglu(Leibniz University Hannover)
European Journal of Pharmaceutical Sciences
July 7, 2025
Cited by 15


Related Papers